VujaDe Sciences

VujaDe Sciences is a biotechnology company dedicated to developing therapies that target cancer metastasis, the primary cause of cancer-related deaths. The company utilizes its proprietary Anti-Metastatic Drug Discovery (AMDD) platform to identify small molecules that induce or maintain a state of dormancy in disseminated tumor cells. By focusing on the biology of the metastatic niche rather than primary tumor growth, VujaDe aims to prevent the recurrence of cancer. Their lead programs are being developed using a comparative oncology approach, testing candidates in both human and veterinary patients to accelerate clinical validation. This strategy allows for the study of naturally occurring metastatic disease in pet dogs, providing high-quality data to inform human clinical trials.